Risk allele for side effects induced by Clozapine identified

Clozapine (CLZ) is a “gold standard” drug for managing treatment-resistant schizophrenia, who do not respond adequately to first-line antipsychotics. However, despite its efficacy, the use of CLZ is significantly restricted by severe side effects, which are rare but potentially life-threatening.